Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response (Q38823641)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 September 2016

Language	Label	Description	Also known as
English	Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response	scientific article published on 7 September 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1 reference

Europe PubMed Central

Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1 reference

based on heuristic

inferred from title

major depressive disorder

1 reference

based on heuristic

inferred from title

Markus M Nöthen

21

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

object named as

Carla Gallo

11

0 references

object named as

Stephan Claes

7

0 references

Frank Bellivier

object named as

Frank Bellivier

6

0 references

object named as

Ole Mors

19

0 references

object named as

Marion Leboyer

14

0 references

object named as

Sven Cichon

28

0 references

Alessandro Serretti

object named as

Alessandro Serretti

31

0 references

4

object named as

Ina Giegling

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

30

object named as

Dan Rujescu

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

24

object named as

Peter Propping

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

26

object named as

David St Clair

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

8

object named as

David A Collier

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Michael C O'Donovan

22

object named as

Michael C O'Donovan

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Rainald Mössner

3

object named as

Rainald Mössner

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Pierandrea Muglia

20

object named as

Pierandrea Muglia

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

James L. Kennedy

13

object named as

James L Kennedy

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Julien Mendlewicz

29

object named as

Julien Mendlewicz

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Ladislav Hosák

2

object named as

Ladislav Hosak

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Miguel Ángel Muñoz-Márquez

17

object named as

Miguel Marquez

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Isabelle Massat

18

object named as

Isabelle Massat

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jorge Ospina-Duque

23

object named as

Jorge Ospina-Duque

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

author name string

Chiara Fabbri

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Laura Mandelli

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Alejo Corrales

9

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Lynn E Delisi

10

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Michael Gill

12

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Amanda Lisoway

15

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Wolfgang Maier

16

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Yongyong Shi

25

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Florence Thibaut

27

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

publication date

7 September 2016

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

5-28

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

C-reactive protein gene variants: independent association with late-life depression and circulating protein levels

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Longitudinal monitoring of the serotonin transporter gene expression to assess major depressive episode evolution

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

MDDScore: confirmation of a blood test to aid in the diagnosis of major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Interleukin-1beta promoter (-31T/C and -511C/T) polymorphisms in major recurrent depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Poor replication of candidate genes for major depressive disorder using genome-wide association data

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association study of CREB1 and childhood-onset mood disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

-308(G/A) TNF-alpha gene polymorphism and risk of depression late in the life.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Genome-wide polygenic scoring for a 14-year long-term average depression phenotype

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Epigenetic modulation of BDNF gene in patients with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Measures of anxiety, sensorimotor function, and memory in male and female mGluR4⁻/⁻ mice

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Genetic risk profiles for depression and anxiety in adult and elderly cohorts

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

A meta-analysis of cytokines in major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA).

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Pathogenetic and therapeutic applications of microRNAs in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Depression and C-reactive protein: population-based Health 2000 Study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Genetics of serotonin receptors and depression: state of the art.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin, serotonin 5-HT(1A) receptors and dopamine in blood peripheral lymphocytes of major depression patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association between adolescent emotional problems and metabolic syndrome: the modifying effect of C-reactive protein gene (CRP) polymorphisms

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Lymphocytes as a neural probe: potential for studying psychiatric disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Expression of neurturin, GDNF, and their receptors in the adult mouse CNS.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes in major depression patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Meta-analysis of molecular imaging of serotonin transporters in major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Identification and replication of a combined epigenetic and genetic biomarker predicting suicide and suicidal behaviors.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The risk for major depression conferred by childhood maltreatment is multiplied by BDNF and SERT genetic vulnerability: a replication study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

No association of genetic variants in BDNF with major depression: a meta- and gene-based analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Promoter variants in IL18 are associated with onset of depression in patients previously exposed to stressful-life events

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Allelic Variation of Human Serotonin Transporter Gene Expression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association study of CREB1 with Major Depressive Disorder and related phenotypes

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and Nutrition Examination survey (NHANES) 1999-2004.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controls

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Mechanisms of the placebo effect in pain and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Interleukin-6 genetic polymorphism and Chinese major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Bioprofiling of platelets in medicated patients with depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

A genome-wide association study of a sustained pattern of antidepressant response

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Dysregulation of leukocyte gene expression in women with medication-refractory depression versus healthy non-depressed controls

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Epigenetic and epistatic interactions between serotonin transporter and brain-derived neurotrophic factor genetic polymorphism: insights in depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Research domain criteria (RDoC): toward a new classification framework for research on mental disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonergic vulnerability and depression: assumptions, experimental evidence and implications.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Gene expression in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

BDNF promoter methylation and genetic variation in late-life depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

A comprehensive network and pathway analysis of candidate genes in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

BDNF promoter methylation and suicidal behavior in depressive patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Quantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in Males

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Increased BDNF promoter methylation in the Wernicke area of suicide subjects.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Is there circannual variation of human platelet 5-HT(2A) binding in depression?

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy Caucasian subjects

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

A longitudinal study of BDNF promoter methylation and genotype with poststroke depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Associations of cytokine gene polymorphisms with post-stroke depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Epistatic interaction of CREB1 and KCNJ6 on rumination and negative emotionality

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonergic gene expression and depression: implications for developing novel antidepressants.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

An integrated quantification method to increase the precision, robustness, and resolution of protein measurement in human plasma samples

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

T-lymphocyte CREB as a potential biomarker of response to antidepressant drugs

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Decreased glial cell line-derived neurotrophic factor levels in patients with depression: a meta-analytic study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Epigenetic regulation of BDNF expression according to antidepressant response.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Heterogeneity in the prognosis of major depression: from the common cold to a highly debilitating and recurrent illness.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association of existing and new candidate genes for anxiety, depression and personality traits in older people

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Platelet 5-HT2A receptor subresponsivity and lethality of attempted suicide in depressed in-patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Blood mononuclear cell proteome suggests integrin and Ras signaling as critical pathways for antidepressant treatment response

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin transporter gene: a new polymorphism may affect response to antidepressant treatments in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The current status of the platelet 5-HT(2A) receptor in depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Cytokine Genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and childhood-onset mood disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484).

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Interleukin-1β is associated with depressive episode in major depression but not in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Gene X environment interactions at the serotonin transporter locus

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Polygenic risk, stressful life events and depressive symptoms in older adults: a polygenic score analysis.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin transporter genotype and function in relation to antidepressant response in Koreans

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Pharmacogenetics in major depression: a comprehensive meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Genotyping serotonin transporter polymorphisms 5-HTTLPR and rs25531 in European- and African-American subjects from the National Institute of Mental Health's Collaborative Center for Genomic Studies

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The potential of SLC6A4 gene methylation analysis for the diagnosis and treatment of major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Prospects for epigenetic research within cohort studies of psychological disorder: a pilot investigation of a peripheral cell marker of epigenetic risk for depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Altered expression of neurotrophic factors in patients with major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association of high-sensitivity C-reactive protein with de novo major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Mood disorders: regulation by metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Initial platelet serotonin (5-HT) transport kinetics predict nortriptyline treatment outcome

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Cyclic-AMP response element binding protein (CREB) in the neutrophils of depressed patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Meta-analysis of the placebo response in antidepressant trials

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Gene-Environment Interaction in Youth Depression: Replication of the 5-HTTLPR Moderation in a Diverse Setting

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: A pilot study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Differential serotonin transport is linked to the rh5-HTTLPR in peripheral blood cells.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

FKBP5 polymorphism is associated with major depression but not with bipolar disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Contribution of common genetic variants to antidepressant response

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Early induction of CREB activation and CREB-regulating signalling by antidepressants.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Analysis of 34 candidate genes in bupropion and placebo remission

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Cytokines and serotonin transporter in patients with major depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

On the outside, looking in: a review and evaluation of the comparability of blood and brain "-omes".

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Genetic predictors of response to antidepressants in the GENDEP project

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

A population-based association study of candidate genes for depression and sleep disturbance.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

New Insights in the Immunobiology of IL-1 Family Members

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Early life adversity and serotonin transporter gene variation interact at the level of the adrenal gland to affect the adult hypothalamo-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association of depressive disorders, depression characteristics and antidepressant medication with inflammation

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association of 2 neurotrophic factor polymorphisms with efficacy of paroxetine in patients with major depressive disorder in a Chinese population

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Imaging genetics studies on monoaminergic genes in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Effects of rapid tryptophan depletion on brain 5-HT(2) receptors: a PET study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Platelet SERT as a peripheral biomarker of serotonergic neurotransmission in the central nervous system.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Low-grade inflammation predicts persistence of depressive symptoms

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Platelet 5-HT(1A) receptor correlates with major depressive disorder in drug-free patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Association of HTR2A T102C and A-1438G polymorphisms with susceptibility to major depressive disorder: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

DNA sequence variants of the FKBP5 gene are associated with unipolar depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Brain-derived neurotrophic factor (BDNF)—Epigenetic regulation in unipolar and bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

5-HT2A: its role in frontally mediated executive function and related psychopathology

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Long-term suicide risk of depression in the Lundby cohort 1947–1997 – severity and gender

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1208843

21 January 2018

Identifiers

10.1080/15622975.2016.1208843

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38823641&oldid=2015070350"